Literature DB >> 25316012

Does autoreactivity have a role in narcolepsy?

Markku Partinen1, Birgitte Rahbek Kornum2, Giuseppe Plazzi3, Poul Jennum4, Ilkka Julkunen5, Outi Vaarala6.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 25316012     DOI： 10.1016/S1474-4422(14)70168-1

Source DB:  PubMed          Journal:  Lancet Neurol        ISSN： 1474-4422            Impact factor:   44.182


× No keyword cloud information.
  7 in total

Review 1.  Neurobiological and immunogenetic aspects of narcolepsy: Implications for pharmacotherapy.

Authors:  Steven T Szabo; Michael J Thorpy; Geert Mayer; John H Peever; Thomas S Kilduff
Journal:  Sleep Med Rev       Date:  2018-11-08       Impact factor: 11.609

Review 2.  Narcolepsy Type 1 as an Autoimmune Disorder: Evidence, and Implications for Pharmacological Treatment.

Authors:  Lucie Barateau; Roland Liblau; Christelle Peyron; Yves Dauvilliers
Journal:  CNS Drugs       Date:  2017-10       Impact factor: 5.749

Review 3.  Treatment paradigms for cataplexy in narcolepsy: past, present, and future.

Authors:  Todd J Swick
Journal:  Nat Sci Sleep       Date:  2015-12-11

4.  Effective treatment of narcolepsy-like symptoms with high-frequency repetitive transcranial magnetic stimulation: A case report.

Authors:  Jian-Bo Lai; Mao-Mao Han; Yi Xu; Shao-Hua Hu
Journal:  Medicine (Baltimore)       Date:  2017-11       Impact factor: 1.889

5.  CD4+ T-Cell Reactivity to Orexin/Hypocretin in Patients With Narcolepsy Type 1.

Authors:  Melanie Ramberger; Birgit Högl; Ambra Stefani; Thomas Mitterling; Markus Reindl; Andreas Lutterotti
Journal:  Sleep       Date:  2017-03-01       Impact factor: 5.849

Review 6.  Profile of pitolisant in the management of narcolepsy: design, development, and place in therapy.

Authors:  Andrea Romigi; Giuseppe Vitrani; Temistocle Lo Giudice; Diego Centonze; Valentina Franco
Journal:  Drug Des Devel Ther       Date:  2018-08-30       Impact factor: 4.162

7.  Amino Acid Variation in HLA Class II Proteins Is a Major Determinant of Humoral Response to Common Viruses.

Authors:  Christian Hammer; Martin Begemann; Paul J McLaren; István Bartha; Angelika Michel; Beate Klose; Corinna Schmitt; Tim Waterboer; Michael Pawlita; Thomas F Schulz; Hannelore Ehrenreich; Jacques Fellay
Journal:  Am J Hum Genet       Date:  2015-10-08       Impact factor: 11.025
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.